This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Andrew Bockus
Director of Chemistry at Circle Pharma, Inc
Speaker

Profile

Andrew T. Bockus, Ph.D., is Director of Chemistry at Circle Pharma, Inc., where he leads thesolid-phase peptide synthesis discovery chemistry team and has served as project team lead onhit-to-lead and lead optimization programs. He has over a decade of experience designingpassively permeable cyclic peptides, including the Cyclin A/B inhibitor CID-078, currently inPhase 1 clinical trials.